BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24565600)

  • 1. Initial characteristics and outcome of hospitalized patients with amiodarone pulmonary toxicity.
    Mankikian J; Favelle O; Guillon A; Guilleminault L; Cormier B; Jonville-Béra AP; Perrotin D; Diot P; Marchand-Adam S
    Respir Med; 2014 Apr; 108(4):638-46. PubMed ID: 24565600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic utility of chest computed tomography scoring for the assessment of amiodarone-induced pulmonary toxicity.
    Kang IS; Kim KJ; Kim Y; Park SH
    Korean J Intern Med; 2014 Nov; 29(6):746-53. PubMed ID: 25378973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thoracic radiography and high resolution computerized tomography in the diagnosis of pulmonary disorders caused by amiodarone].
    Polverosi R; Zanellato E; Doroldi C
    Radiol Med; 1996; 92(1-2):58-62. PubMed ID: 8966274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone-induced acute lung toxicity in an ICU setting.
    Skroubis G; Galiatsou E; Metafratzi Z; Karahaliou A; Kitsakos A; Nakos G
    Acta Anaesthesiol Scand; 2005 Apr; 49(4):569-71. PubMed ID: 15777308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HRCT findings of amiodarone pulmonary toxicity: clinical and radiologic regression.
    Poll LW; May P; Koch JA; Hetzel G; Heering P; Mödder U
    J Cardiovasc Pharmacol Ther; 2001 Jul; 6(3):307-11. PubMed ID: 11584337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of amiodarone pulmonary toxicity in patients treated with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kosseifi SG; Halawa A; Bailey B; Micklewright M; Roy TM; Byrd RP
    Ther Adv Respir Dis; 2009 Dec; 3(6):289-94. PubMed ID: 19850648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Early diagnosis of amiodarone-induced pulmonary toxicity: are repeated lung function tests of any value?].
    Ulrik CS; Aldershvile J
    Ugeskr Laeger; 1996 Jun; 158(24):3445-7. PubMed ID: 8650812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and predictors of pulmonary toxicity in Japanese patients receiving low-dose amiodarone.
    Yamada Y; Shiga T; Matsuda N; Hagiwara N; Kasanuki H
    Circ J; 2007 Oct; 71(10):1610-6. PubMed ID: 17895560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Amiodarone pulmonary toxicity].
    Reĭngardene DI; Azaravichene AP; Korobkova IZ
    Vestn Rentgenol Radiol; 2002; (1):43-7. PubMed ID: 12715450
    [No Abstract]   [Full Text] [Related]  

  • 10. [Late postoperative amiodarone pulmonary toxicity].
    Alonso-Fernández A; Alvarez-Sala R; Mediano O; Torres I; Moreno I
    An Med Interna; 2003 Aug; 20(8):419-20. PubMed ID: 14516264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiodarone induced pulmonary toxicity.
    Verswijvel G; Franssens Y; Deraemaeker L; Leyssens G; Govaerts E; Theunissen P
    J Belge Radiol; 1998 Feb; 81(1):9-10. PubMed ID: 9563268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nodular alveolar pattern of presentation for amiodarone pulmonary toxicity].
    González Gordaliza MC; Vicente Bártulos A; Sánchez Corral JA; Bernal Morell E
    Radiologia; 2006; 48(2):99-102. PubMed ID: 17058375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of and effects of angiotensin system antagonists on amiodarone-induced pulmonary toxicity.
    Nikaido A; Tada T; Nakamura K; Murakami M; Banba K; Nishii N; Fuke S; Nagase S; Sakuragi S; Morita H; Ohe T; Kusano KF
    Int J Cardiol; 2010 Apr; 140(3):328-35. PubMed ID: 19106010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiodarone-induced alveolar haemorrhage: a rare complication of a common medication.
    Tanawuttiwat T; Harindhanavudhi T; Hanif S; Sahloul MZ
    Heart Lung Circ; 2010 Jul; 19(7):435-7. PubMed ID: 20356785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amiodarone induced pulmonary toxicity mimicking malignancy at initial presentation.
    Eyselbergs M; Pilate I; Rombouts H; Vanhoenacker FM
    JBR-BTR; 2012; 95(2):109. PubMed ID: 22764676
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute amiodarone-induced lung toxicity.
    Oh E; Siddiqui N; Worringer E; Schroeder K; Markowiak S; Alrehaili M; Safi F; Hinch BT; Assaly R
    Am J Med Sci; 2015 Jan; 349(1):89. PubMed ID: 24051954
    [No Abstract]   [Full Text] [Related]  

  • 17. Amiodarone-induced alveolar hemorrhage.
    Iskandar SB; Abi-Saleh B; Keith RL; Byrd RP; Roy TM
    South Med J; 2006 Apr; 99(4):383-7. PubMed ID: 16634249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary masses in a patient with blue-gray cutaneous hyperpigmentation.
    Facchini G; Forte S; Podda P; Piro F; Carlone S
    Eur Rev Med Pharmacol Sci; 2008; 12(2):113-6. PubMed ID: 18575161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pulmonary parenchymal infiltrates on thoracic CT of a patient in treatment with amiodarone].
    García de Luca MD; Jurado Gámez B; de Toro Torres E; Izquierdo Palomares L; Trujillo-Santos AJ; García López P
    An Med Interna; 2002 Nov; 19(11):607-8. PubMed ID: 12522909
    [No Abstract]   [Full Text] [Related]  

  • 20. [Amiodarone pulmonary toxicity].
    Mazzei L; Sposato B; Propati A; Gidaro M; Sciotto V; De Angelis G
    Recenti Prog Med; 1999 Dec; 90(12):658-62. PubMed ID: 10676107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.